SVB Leerink downgraded Radius Health (NASDAQ:RDUS) to “market perform” from “outperform” and halved its price target to $17 from $34, citing the company’s pipeline outlook. The stock closed at $14.06 on July 7. “We...
Stifel initiated coverage of Radius Health (NASDAQ:RDUS) with a “hold” rating and $20 target price. The stock closed at $17.18, up $1.43, on April 23. Analyst Annabel Samimy writes that Radius established a solid...